NEKTAR THERAPEUTICS shareholders Q1 2021

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

NEKTAR THERAPEUTICS shareholders Q1 2021
NameSharesValueWeighting ↓
CANADA PENSION PLAN INVESTMENT BOARD 3,251$65,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Concord Wealth Partners 50$1,0000.00%
BANK OF MONTREAL /CAN/ 25,956$499,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 6,083$122,0000.00%
BANK OF AMERICA CORP /DE/ 112,374$2,247,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
COWEN AND COMPANY, LLC 5,000$7,0000.00%
COWEN AND COMPANY, LLC 5,000$7,0000.00%
West Oak Capital, LLC 30$1,0000.00%
QUADRANT CAPITAL GROUP LLC 154$3,0000.00%
IFP Advisors, Inc 35$1,0000.00%
ENVESTNET ASSET MANAGEMENT INC 16,710$334,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 1,015$20,0000.00%
EARNEST PARTNERS LLC 83$2,0000.00%
Citadel Advisors 83,100$1,662,0000.00%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 40$1,0000.00%
Standard Family Office LLC 51$1,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 60,000$1,200,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 82,600$1,652,0000.00%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q1 2021. To view NEKTAR THERAPEUTICS's shareholder history, click here.